India has nearly 30 million Hepatitis B cases, WHO 2024 report shows. Experts warn mother‑to‑child transmission remains a silent threat, but timely screening, vaccination, and treatment can prevent ...

H1 total sales growth of 11.4% at CER1, or 9.7% as reported, driven by the three therapeutic areas: 95.7% in Rare Disease, ...

H1 total sales growth of 11.4% at CER1, or 9.7% as reported, driven by the three therapeutic areas: 95.7% in Rare Disease, 9.7% in Neuroscience, and 6.4% in OncologyH1 core operating income of €656m, ...